Stefan Eirefelt Selected Research

Stefan Eirefelt Research Topics

3	Inflammation (Inflammations) 01/2022 - 11/2008
2	Atrophy 01/2022 - 01/2020
2	Atopic Dermatitis (Atopic Eczema) 12/2020 - 01/2020
1	Skin Diseases (Skin Disease) 01/2022
1	Pruritus (Itching) 01/2018
1	Prurigo 01/2018
1	Lung Diseases (Lung Disease) 10/2017
1	Edema (Dropsy) 10/2017
1	Respiratory Tract Diseases (Respiratory Tract Disease) 10/2017
1	Pneumonia (Pneumonitis) 11/2008
1	Bronchial Hyperreactivity 11/2008
1	Asthma (Bronchial Asthma) 11/2008
1	Airway Remodeling 11/2008

2	GlucocorticoidsIBA 01/2022 - 01/2020
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2022 - 10/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2017 - 11/2008
1	Betamethasone Valerate (Betamethasone 17 Valerate)FDA LinkGeneric 01/2022
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2022
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2022
1	Clobetasol (Clobetasol Propionate)FDA LinkGeneric 01/2022
1	Phosphodiesterase 4 InhibitorsIBA 12/2020
1	SteroidsIBA 01/2020
1	Aprepitant (Emend)FDA Link 01/2018
1	Substance PIBA 01/2018
1	2,2,2- trifluoro- N- (1- ((1- (4- fluorophenyl)- 1H- indazol- 5- yl)oxy)- 1- (3- methoxyphenyl)- 2- propanyl)acetamideIBA 10/2017
1	Fluticasone (Cutivate)FDA LinkGeneric 10/2017
1	Ether (Diethyl Ether)IBA 10/2017
1	IndazolesIBA 10/2017
1	velsecoratIBA 10/2017
1	PowdersIBA 10/2017
1	AllergensIBA 11/2008
1	Budesonide (Pulmicort)FDA LinkGeneric 11/2008
1	Therapeutic UsesIBA 11/2008
1	Formoterol Fumarate (Oxis)FDA Link 11/2008

2	Therapeutics 01/2020 - 11/2008
1	Drug Therapy (Chemotherapy) 11/2008